retatrutide phase 3 trials VisualAbstract: reduces body weight by 17.5% in patients with obesity Initial Reta Phase 3 Trials

and (3) "No, and I do not plan to take them." Figure 1 shows that 11.8 percent of adults reported using GLP-1 agonists in 2025 about the same percentage of users reported in 2023 by KFF

this finding should be interpreted accordingly [1] [3] Phase 3 trials are ongoing

10.1038/nrd.2015.4 189 rskovC.RabenhjL.WettergrenA.KofodH.HolstJ

During a May 2024 episode of The Kelly Clarkson Show, Kelly discussed her experience with weight loss medication with guest Whoopi Goldberg

PREMIUM MEDSPA IN PORT SAINT LUCIE, 34952 | LUXE WELLNESS MED SPA | PREMIUM MEDSPA IN PORT SAINT LUCIE, 34952 | LUXE WELLNESS MED SPA | Weight Loss GLP-1 weight loss treatments are prescription-based medications that may help support weight management by influencing appetite regulation and metabolism